Thomas Lund
- General Health Professions top 5%
- Hematology top 5%
- Oncology
- Pharmacology top 5%
- Molecular Biology
- Co-authors
- Niels AbildgaardEbbe VilladsenMerete LabriolaMika KivimäkiKarl Bang ChristensenTorben PlesnerJean‐Marie DelaisséDavid Sherson
- Topics
- Multiple Myeloma Research and Treatments (23 papers)Bone health and treatments (13 papers)Peptidase Inhibition and Analysis (7 papers)
- Journals
- Journal of Clinical InvestigationSHILAP Revista de lepidopterologíaBlood
- Partner nations
- DenmarkUnited StatesNorway
In The Last Decade
Thomas Lund
30 papers receiving 652 citations
Peers
Comparison fields: 5 of 91
- General Health Professions 218
- Hematology 202
- Oncology 193
- Pharmacology 175
- Molecular Biology 151
Countries citing papers authored by Thomas Lund
This map shows the geographic impact of Thomas Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Lund more than expected).
Fields of papers citing papers by Thomas Lund
This network shows the impact of papers produced by Thomas Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Lund. The network helps show where Thomas Lund may publish in the future.
Co-authorship network of co-authors of Thomas Lund
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Lund. A scholar is included among the top collaborators of Thomas Lund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Lund. Thomas Lund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 1 | |
| 10 | 5 | |
| 11 | 4 | |
| 12 | 60 | |
| 13 | 2 | |
| 14 | 22 | |
| 15 | 36 | |
| 16 | 114 | |
| 17 | 45 | |
| 18 | 143 | |
| 19 | 0 dB FS + Levels in Digital Mastering | 1 |
| 20 | Enhanced Localization in 5.1 Production | 4 |
About Thomas Lund
Thomas Lund is a scholar working on Hematology, Medical Laboratory Technology and Oncology, having authored 35 papers that have together received 674 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (23 papers), Bone health and treatments (13 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Medical Laboratory Technology (37 citations), Hematology (202 citations) and Radiological and Ultrasound Technology (66 citations). Thomas Lund has collaborated with scholars based in Denmark, United States and Norway. Frequent co-authors include Niels Abildgaard, Ebbe Villadsen, Merete Labriola, Mika Kivimäki, Karl Bang Christensen, Torben Plesner, Jean‐Marie Delaissé, David Sherson, Jens Olsen and Ute Bültmann. Their work appears in journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.